Save
Email
Print
Share
RSSBrowse News Stories
491 to 500 of 17,851 stories
view headlines only
-
Stroke Risk in Elderly Treated With Antipsychotics Is Newly Linked to Specific Drug Actions
March 11, 2013 — Antipsychotic administration in the elderly is associated with an increased risk for cerebrovascular accident, more commonly known as stroke; a new study provides additional insight into this ... > full story -
Niacin Therapy Shows No Benefits, Has Some Harmful Effects
March 11, 2013 — A highly anticipated study evaluating a combination of the vitamin niacin with the anti-flushing agent laropiprant finds the therapy provides no benefit to and may even be harmful for patients with ... > full story -
New Anti-Clotting Drug More Effective Than Current Treatment, Study Suggests
March 11, 2013 — A new and experimental anti-clotting drug, cangrelor, proved better than the commonly used clopidogrel and was significantly more effective at preventing blood clots in a large trial of patients who ... > full story -
New Biolimus Stent Equal to Everolimus Stent at One Year
March 11, 2013 — In a match-up of Japan's top drug-releasing stent and a new device featuring a biodegradable coating, the newcomer delivered statistically comparable one-year results, according to new ... > full story -
Drug Protects Against Kidney Injury from Imaging Dye in ACS Patients
March 11, 2013 — High doses of a popular cholesterol-lowering drug significantly reduced the rate of acute kidney injury caused by dye used in imaging in acute coronary syndrome patients who underwent a coronary ... > full story -
Multiple Sclerosis Research
Multiple Sclerosis
Chronic Illness
Diseases and Conditions
Disorders and Syndromes
Pharmacology
Common Multiple Sclerosis Drugs Taken Together Do Not Reduce Relapse Risk
March 11, 2013 — A recent clinical trial found that interferon²-1a (INF) and glatiramer acetate (GA), two of the most commonly prescribed drugs for multiple sclerosis (MS), provide no additional clinical benefit ... > full story -
Anemia Drug Does Not Improve Health of Anemic Heart Failure Patients, Study Shows
March 11, 2013 — Researchers have found that a commonly used drug to treat anemia in heart failure patients -- darbepoetin alfa -- does not improve patients' health, nor does it reduce their risk of death from heart ... > full storyMore: -
Trio of Biomarkers May Help Identify Kidney Cancer in Early Stages
March 11, 2013 — A new immunoassay that tests for the presence of three biomarkers appears to be a valid screening method for the early detection of malignant kidney cancer, according to new ... > full story -
A New Drug Reduces Heart Damage, Study Suggests
March 10, 2013 — A single dose of an investigational anti-inflammatory drug called inclacumab considerably reduces damage to heart muscle during angioplasty (the opening of a blocked artery), according to a recent ... > full story -
Early Detection of MS Treatment Complication May Improve Survival
March 10, 2013 — The drug natalizumab is effective for treating multiple sclerosis (MS), but it increases the risk of a rare but potentially fatal brain infection called progressive multifocal leukoencephalopathy ... > full story
Search ScienceDaily
Number of stories in archives: 137,350
more 
